There is an ongoing phase 2/3 randomised, double-blind, placebo-controlled trial (NCT06126315) of the biological and clinical effects of acetyl-l-carnitine planning to recruit ~250 patients [88]
Call your healthcare provider right away if you experience: Persistent vomiting Severe abdominal pain, especially if it radiates to the back Signs of dehydration, such as dizziness, very dark urine, weakness, or inability to keep fluids down Severe constipation or no bowel movement with pain and bloating Symptoms of gallbladder problems, such as upper right abdominal pain, fever, yellowing of the skin or eyes, or clay-colored stools Nausea that does not improve or prevents you from eating enough Nutrition support is powerful, but it does not replace medical evaluation when symptoms are severe
PeptIQ lets you log every injection and supplement, set reminders, and monitor how your protocol is actually performing over time
DC65821 Upadacitinib hemihydrate Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor with an IC50 of 43 nM, being developed for the treatment of several autoimmune disorders
In: The role of ROS in the progression and treatment of castration-resistant prostate cancer [thesis]
